"Novel neural biomarkers of mood disorder risk: replication, treatment targets and next steps"
Mary L. Phillips, MD
Distinguished Professor in Psychiatry and Clinical and Translational Science Pittsburgh Foundation
Emmerling Endowed Chair in Psychotic Disorders Director, Center for Research in Translational & Developmental Affective Neuroscience
Department of Psychiatry, University of Pittsburgh
Dr. Phillips uses state-of-the-art brain imaging techniques to study biological processes underlying mood disorder risk. She has identified brain activity markers reflecting these processes to help improve early diagnosis and risk identification in youth and young adults; and targets these markers to develop novel brain stimulation treatments for mood disorders.
Objectives
The activity is designed to help the learner
- To explain how measures of large scale neural network activity predict future risk of mania and depression
- To describe research replicating predictive relationships among neural biomarkers and mania and depression risk
- To demonstrate how these novel neural markers can be targeted by neuromodulation as a way forward to develop new treatments for mood disorders
This talk is sponsored by the Luton Lecture Fund Department of Psychiatry and Behavioral Sciences. This educational activity received no commercial support.